REFERENCES
- Barnetson RStC. Allergy and the skin. Allergy. Immunological and clinical aspects, M K Lessof. John Wiley & Sons, New York 1984; 219–52
- Warin R P. Food and factors in urticaria. J Hum Nutr 1976; 30: 179–86
- O'Donnell B F, Lawlor F, Simpson J, et al. The impact of chronic urticaria on the quality of life. Br J Dermatol 1997; 136: 197–201
- Grattan C EH, Francis D M, Hide M, Greaves M W. Detection of circulating histamine releasing autoantibodies with functional properties of anti-IgE in chronic urticaria. Clin Exp Allergy 1991; 21: 695–704
- Hide M, Francis D M, Grattan C EH, et al. Autoantibodies against the high affinity IgE receptor as a cause of histamine release in chronic urticaria. N Engl J Med 1993; 328: 1599–604
- Mathews K P. The urticarias. Current concepts of pathogenesis and treatment. Drugs 1985; 30: 552–60
- Soter N A. Urticaria: current therapy. J Allergy Clin Immunol 1990; 86: 1009–14
- Simons F ER, Simons K J. The pharmacology and use of H1-receptor-antagonist drugs. N Engl J Med 1994; 330: 1663–70
- Markham A, Wagstaff A J. Fexofenadine. Drugs 1998; 55(2)269–76
- Garteiz D A, Hook R H, Walker B J, Okerholm R A. Pharmacokinetics and biotransformation studies of terfenadine in man. Arzneimittelforschung 1982; 32: 1185–90
- Lippert C, Ling J, Brown P, et al. Mass balance and pharmacokinetics of fexofenadine HCl in healthy, male volunteers. Pharm Res 1995; 12(Suppl 9)S390, (abstract).
- Pratt C, Mason J, Russell T, Ahlbandt R. Effect of fexofenadine on corrected QT interval (QTc). Allergy 1997; 52(Suppl 37)67, (abstract 195).
- Tinkleman D, Falliers C, Bronsky E, et al. Efficacy and safety of fexofenadine HCl in fall seasonal allergic rhinitis. J Allergy Clin Immunol 1996; 97: 435, (abstract).
- Bernstein D, Schoenwetter W, Nathan R, et al. Efficacy and safety of fexofenadine HCl for seasonal allergic rhinitis. Ann Allergy Asthma Immunol 1997; 79: 443–8
- Lindquist M, Edwards I R. Risks of non-sedating antihistamines. Lancet 1997; 349: 1322
- Russell T, Stolz M, Eller M, et al. Acute and sub chronic dose tolerance of fexofenadine HCl in healthy male subjects. Ann Allergy Asthma Immunol 1996; 76(1)27, (abstract).
- Woosley R L, Chen Y, Freiman J P, Gillis R A. Mechanism of the cardiotoxic actions of terfenadine. JAMA 1993; 269: 1532–6
- Greaves M. Antihistamine treatment: a patient self-assessment method in chronic urticaria. BMJ 1981; 283: 1435–6
- Bleehen S S, Thomas S E, Greaves M W, et al. Cimetidine and chlorpheniramine in the treatment of chronic idiopathic urticaria: a multi-centre randomized double-blind study. Br J Dermatol 1987; 117: 81–8
- Janssens M ML, Howarth P H. The antihistamines of the nineties. Clin Rev Allergy 1993; 11: 111–53
- Tanner L A, Reilly M, Meltzer E O, et al. Evaluation of quality of life and health economic measures in patients treated with fexofenadine HCl for seasonal allergic rhinitis. Ann Allergy Asthma Immunol 1997; 78(1)125, (abstract).